GILBERT; Mark J.
Patent Applications and Registrations
Patent applications and USPTO patent grants for GILBERT; Mark J..The latest application filed is for "methods and compositions for adoptive cell therapy".
- GILBERT; Mark J. - Seattle WA
| Patent | Date |
|---|---|
| Methods And Compositions For Adoptive Cell Therapy App 20220280642 - GILBERT; Mark J. | 2022-09-08 |
| Articles of manufacture and methods for treatment using adoptive cell therapy Grant 11,413,310 - Albertson , et al. August 16, 2 | 2022-08-16 |
| Methods and compositions for adoptive cell therapy Grant 11,266,739 - Gilbert March 8, 2 | 2022-03-08 |
| Procaspase Combination Therapy For Glioblastoma App 20210290616 - Hergenrother; Paul J. ; et al. | 2021-09-23 |
| Methods For Dosing And For Modulation Of Genetically Engineered Cells App 20210198372 - ALBERTSON; Tina ; et al. | 2021-07-01 |
| Procaspase 3 Activation By Combination Therapy App 20210128551 - HERGENROTHER; Paul J. ; et al. | 2021-05-06 |
| Procaspase 3 activation by combination therapy Grant 10,888,560 - Hergenrother , et al. January 12, 2 | 2021-01-12 |
| Procaspase combination therapy for glioblastoma Grant 10,874,666 - Hergenrother , et al. December 29, 2 | 2020-12-29 |
| Methods And Compositions For Dosing In Adoptive Cell Therapy App 20200054680 - GILBERT; Mark J. | 2020-02-20 |
| Methods and compositions for dosing in adoptive cell therapy Grant 10,507,219 - Gilbert Dec | 2019-12-17 |
| Methods And Compositions Related To Toxicity Associated With Cell Therapy App 20190277858 - LI; He ; et al. | 2019-09-12 |
| Procaspase 3 Activation By Combination Therapy App 20190099418 - HERGENROTHER; Paul J. ; et al. | 2019-04-04 |
| Procaspase Combination Therapy For Glioblastoma App 20190099419 - HERGENROTHER; Paul J. ; et al. | 2019-04-04 |
| Procaspase 3 activation by combination therapy Grant 10,085,977 - Hergenrother , et al. October 2, 2 | 2018-10-02 |
| Procaspase combination therapy for glioblastoma Grant 10,085,978 - Hergenrother , et al. October 2, 2 | 2018-10-02 |
| Potent anticancer activity via dual compound activation Grant 9,592,229 - Hergenrother , et al. March 14, 2 | 2017-03-14 |
| Procaspase Combination Therapy For Glioblastoma App 20170042886 - HERGENROTHER; Paul J. ; et al. | 2017-02-16 |
| Procaspase 3 Activation By Combination Therapy App 20160346277 - HERGENROTHER; Paul J. ; et al. | 2016-12-01 |
| Procaspase combination therapy for glioblastoma Grant 9,421,202 - Hergenrother , et al. August 23, 2 | 2016-08-23 |
| Procaspase 3 activation by combination therapy Grant 9,399,035 - Hergenrother , et al. July 26, 2 | 2016-07-26 |
| Methods And Compositions For Dosing In Adoptive Cell Therapy App 20160206656 - GILBERT; Mark J. | 2016-07-21 |
| Methods And Compositions For Adoptive Cell Therapy App 20160158359 - GILBERT; Mark J. | 2016-06-09 |
| Potent Anticancer Activity Via Dual Compound Activation App 20150099759 - Hergenrother; Paul J. ; et al. | 2015-04-09 |
| Procaspase Combination Therapy For Glioblastoma App 20150025083 - Hergenrother; Paul J. ; et al. | 2015-01-22 |
| Procaspase 3 Activation By Combination Therapy App 20150017264 - Hergenrother; Paul J. ; et al. | 2015-01-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 